Drugs / MAG-EPA
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03753334 | Jul 2017 → Dec 2023 overdue | prostate cancer | CHU de Quebec-Universite Laval | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MAG-EPA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03753334 ↗ |
| Modality | Other / unclassified | “dietary supplementation” NCT03753334 ↗ |